Refine
Has Fulltext
- yes (24)
Is part of the Bibliography
- yes (24)
Year of publication
Document Type
- Journal article (23)
- Book (1)
Keywords
- SARS-CoV-2 (7)
- HIV (4)
- Polyadenylierung (2)
- RNS (2)
- Virologie (2)
- ceramides (2)
- foamy viruses (2)
- 1,2-benzisothiazolinone (1)
- AKT-signaling (1)
- Calu-3 (1)
- Epidemiologie (1)
- Flt3L (1)
- Foamy virus (1)
- GagPol fusion protein (1)
- HIV diagnosis and management (1)
- HIV-1 subtype AG (1)
- HIV-1; subtype C; proviral plasmid; viral replication; resistance assays; Vpu; CD317; CD4 (1)
- IL‐10 (1)
- Integrase (1)
- KRAS (1)
- LIF (1)
- Lehrbuch (1)
- MEK/ERK-signaling (1)
- Major splice donor (1)
- Medizin (1)
- PARM (1)
- PCLS (1)
- Pathogenese (1)
- Polyadenylation (1)
- RNA export (1)
- RNA structure (1)
- RNA-Export (1)
- Regulation of protease activity (1)
- Retroviren (1)
- Reverse Transkription (1)
- T cells (1)
- Tamoxifen (1)
- Tansania (1)
- Tanzania (1)
- Therapie (1)
- Transkription (1)
- Vero E6 (1)
- Viren (1)
- acetylsalicylic acid (1)
- acid sphingomyelinase (1)
- amplicon sequencing (1)
- animal models (1)
- anthocyanin (1)
- antimicrobial resistance (1)
- antiretroviral therapy (1)
- antiretrovirals (1)
- antiviral activity (1)
- antivirals (1)
- aorta ring (1)
- aspirin (1)
- astaxanthin (1)
- azapeptide nitriles (1)
- azido-ceramides (1)
- azidothymidine (1)
- bilberry (1)
- black currant (1)
- branch point (1)
- cDC2 subset (1)
- cell differentiation (1)
- cell line specificity pyridyl indole carboxylates (1)
- cell line-specificity (1)
- ceramidase (1)
- ceramide (1)
- cholera (1)
- cytokines (1)
- dendritic cells (1)
- dengue virus (1)
- direct-acting antivirals (1)
- drug discovery (1)
- endothelial cell infection (1)
- evolution (1)
- fluoxetine (1)
- foamy virus (1)
- genetic conservation (1)
- hACE2 (1)
- hepadnaviruses (1)
- herpesvirus (1)
- immune evasion (1)
- infectivity assays (1)
- measels virus (1)
- multi-drug resistance (1)
- multiple myeloma (1)
- mutation databases (1)
- peptidomimetics (1)
- phospholipidosis (1)
- plasma membrane (1)
- precision-cut lung slices (1)
- protease inhibitors (1)
- purine-rich element (1)
- recombination (1)
- regulatory T cells (1)
- retroviruses (1)
- reverse transcriptase (1)
- ribonuclease H (1)
- salicylic acid (1)
- sequence databases (1)
- small interfering RNAs (1)
- sphingolipid (1)
- sphingolipids (1)
- sphingosine-1-phosphate (1)
- splice regulation (1)
- toxins (1)
- viral epidemiology (1)
- viral infection (1)
- virus budding (1)
- virus entry (1)
- virus replication (1)
Institute
- Institut für Virologie und Immunbiologie (24)
- Institut für Organische Chemie (3)
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (3)
- Theodor-Boveri-Institut für Biowissenschaften (3)
- Institut für Anatomie und Zellbiologie (1)
- Institut für Humangenetik (1)
- Institut für Physikalische und Theoretische Chemie (1)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (1)
- Medizinische Klinik und Poliklinik I (1)
- Medizinische Klinik und Poliklinik II (1)
Recently, Tummino et al. reported that 34 compounds, including Chloroquine and Fluoxetine, inhibit SARS-CoV-2 replication by inducing phospholipidosis, although Chloroquine failed to suppress viral replication in Calu-3 cells and patients. In contrast, Fluoxetine represses viral replication in human precision-cut lung slices (PCLS) and Calu-3 cells. Thus, it is unlikely that these compounds have similar mechanisms of action. Here, we analysed a subset of these compounds in the viral replication and phospholipidosis assays using the Calu-3 cells and PCLS as the patient-near system. Trimipramine and Chloroquine induced phospholipidosis but failed to inhibit SARS-CoV-2 replication in Calu-3 cells, which contradicts the reported findings and the proposed mechanism. Fluoxetine, only slightly induced phospholipidosis in Calu-3 cells but reduced viral replication by 2.7 orders of magnitude. Tilorone suppressed viral replication by 1.9 orders of magnitude in Calu-3 cells without causing phospholipidosis. Thus, induction of phospholipidosis is not correlated with the inhibition of SARS-CoV-2, and the compounds act via other mechanisms. However, we show that compounds, such as Amiodarone, Tamoxifen and Tilorone, with antiviral activity on Calu-3 cells, also inhibited viral replication in human PCLS. Our results indicate that antiviral assays against SARS-CoV-2 are cell-line specific. Data from Vero E6 can lead to non-transferable results, underlining the importance of an appropriate cell system for analysing antiviral compounds against SARS-CoV-2. We observed a correlation between the active compounds in Calu-3 cells and PCLS.